PNP THERAPEUTICS, INC.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2000-01-01
- Employees
- 1
- Market Cap
- -
Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Safety Study of Adenovirus/PNP Coupled With Fludarabine Phosphate to Treat Solid Tumors
Phase 1
Completed
- Conditions
- Head and Neck Cancer
- First Posted Date
- 2011-03-08
- Last Posted Date
- 2015-06-10
- Lead Sponsor
- PNP Therapeutics, Inc.
- Target Recruit Count
- 12
- Registration Number
- NCT01310179
- Locations
- 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States
🇺🇸Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States
News
No news found